Chargement en cours...
Vicriviroc and Peripheral Neuropathy: Results from AIDS Clinical Trials Group 5211
PURPOSE: To evaluate the effect of vicriviroc (VCV) on peripheral neuropathy (PN), the most prevalent neurological complication of HIV infection in HIV-1–infected treatment-experienced population. METHOD: A5211 is a randomized placebo-controlled trial evaluating VCV in treatment-experienced HIV part...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2010
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2958041/ https://ncbi.nlm.nih.gov/pubmed/20400411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1310/hct1101-51 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|